other material
confidence high
sentiment positive
materiality 0.80
Vaxcyte raises $544.5M net via public offering of stock and pre-funded warrants
Vaxcyte, Inc.
- Issued 11.2M shares at $41.00 and pre-funded warrants for 1M shares at $40.999 each.
- Underwriters exercised option to purchase additional 1.83M shares, increasing total proceeds.
- Net proceeds expected to be $544.5M after underwriting discounts and expenses.
- Closing expected April 21, 2023, subject to customary conditions.